8.44
+0.60%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Jiuzhitang Co
Its shares trade on Shenzhen under the ticker 000989.SZ. It has been listed since 28 June 2000. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.21bn and net income of CN¥222.6m. At that date it held total assets of CN¥5.44bn and shareholders' equity of CN¥3.72bn.
Jiuzhitang Co., Ltd. is engaged in the developing, manufacturing, wholesaling and retailing of Chinese medicines, Chinese medicinal materials, Western medicines, biological pharmaceuticals, biological preparations, chemical raw materials, chemical reagents and health food. The company is headquartered in Beijing, Beijing. The company went IPO on 2000-06-28. is a China-based company principally engaged in the research, development, production and distribution of Chinese patent drugs. The firm provides products through three categories, which include over the counter (OTC) drugs, prescription drugs and comprehensive health series. The Company’s main products include Liuwei Dihuang pills, Xiaoyao pills, Shuxuetong injection, compound Jiangzhi tablets and E-Jiao series health products, among others. The firm distributes its products in domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 28 Jun 2000
- Employees
- 3,416
- Website
- hnjzt.com ↗
Leadership
Pay as last reported
- Mr. Guangyuan SunChairman of the Board, since 2024
- Mr. Zhen'guo LiVice Chairman of the Board, General Manager, since 2016CN¥2.0m
- Mr. Lubao ZhouChief Financial Officer
- Mr. Yansong GaoDeputy General Manager, since 2020CN¥1.2m
- Ms. Chunfeng LiuDeputy General Manager, since 2020CN¥1.5m
- Mr. Yongsheng WuDeputy General ManagerCN¥1.2m
- Mr. Xiangping XuDeputy General Manager, since 2011CN¥1.5m
- Mr. Liangbin ZhangDeputy General ManagerCN¥1.2m
- Mr. Chenxiao HanSecretary of the BoardCN¥1.2m
- Mr. Jinfeng BoDirector
- Mr. Ming LuDirector
- Mr. Lianbin SunDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Jiuzhitang Co Ltd employs 3,416 full-time employees in Beijing, China.
- The company develops and distributes Liuwei Dihuang pills and Xiaoyao pills as key products.
- Jiuzhitang Co Ltd focuses on Chinese patent drugs and OTC drugs in the domestic market.
Weaknesses
- Jiuzhitang Co Ltd has no international presence beyond China's domestic market.
- The company's product range is limited to Chinese medicines and health food.
- Jiuzhitang Co Ltd's business is solely distributed within China.
Opportunities
- Jiuzhitang Co Ltd can expand its product line to include Western medicines and biological pharmaceuticals.
- The domestic market offers growth potential for Chinese patent drugs and health food.
- Jiuzhitang Co Ltd can leverage its OTC drug distribution network for new product launches.
Threats
- Jiuzhitang Co Ltd faces competition from other Chinese pharmaceutical companies in the domestic market.
- The company's reliance on the domestic market exposes it to regulatory changes in China.
- Jiuzhitang Co Ltd must adapt to evolving consumer preferences in the Chinese health care sector.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.